Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109788

Captopril-induced Changes in Prostaglandin Production: RELATIONSHIP TO VASCULAR RESPONSES IN NORMAL MAN

Stephen L. Swartz, Gordon H. Williams, Norman K. Hollenberg, Lawrence Levine, Robert G. Dluhy, and Thomas J. Moore

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Swartz, S. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Williams, G. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Hollenberg, N. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Levine, L. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Dluhy, R. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Radiology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02154

Find articles by Moore, T. in: PubMed | Google Scholar

Published June 1, 1980 - More info

Published in Volume 65, Issue 6 on June 1, 1980
J Clin Invest. 1980;65(6):1257–1264. https://doi.org/10.1172/JCI109788.
© 1980 The American Society for Clinical Investigation
Published June 1, 1980 - Version history
View PDF
Abstract

Captopril is a potent hypotensive agent whose efficacy has hitherto been attributed to its ability to alter either angiotensin II formation or kinin degradation. Our purpose was to examine captopril's acute effect on prostaglandin production, because changes in neither the renin-angiotensin nor the kallikrein-kinin systems appear adequate to account for the fall in arterial pressure. The plasma levels of angiotensin II, kinins, and prostaglandins were determined in response to increasing doses (5, 12.5, and 25 mg) of captopril and these responses were compared with the change in arterial pressure observed in nine supine normal male subjects studied on both a high (200 meq) and low (10 meq) sodium intake.

Captopril significantly (P < 0.01) increased the levels of the 13,14-dihydro-15-keto metabolite of prostaglandin E2 (PGE2-M), a potent vasodilator, with similar responses being observed on both a high and a low sodium intake. No significant changes in the plasma levels of 6-keto-prostaglandin F 1α, or thromboxane B2, the stable products of prostacyclin and thromboxane A2, respectively, occurred.

The depressor response to captopril correlated with the change in PGE2-M (r = 0.52, t = 5.44, P < 0.0001). On the other hand, although significant (P < 0.02) decrements in angiotensin II and increments in plasma kinins accompanied the hypotensive response in sodium-restricted subjects, in sodium-loaded subjects where the renin-angiotensin system was suppressed, no change in angiotensin II, and only a modest change in kinins was noted, even though significant (P < 0.01) decrements in diastolic blood pressure occurred (−10±2 mm Hg).

Thus, changes in depressor prostaglandin production can better account for the hypotensive response to captopril, thereby extending to yet another vasoactive system an influence by this class of drugs and providing a new approach to dissecting the abnormality in the control of vascular tone in patients with hypertension.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1257
page 1257
icon of scanned page 1258
page 1258
icon of scanned page 1259
page 1259
icon of scanned page 1260
page 1260
icon of scanned page 1261
page 1261
icon of scanned page 1262
page 1262
icon of scanned page 1263
page 1263
icon of scanned page 1264
page 1264
Version history
  • Version 1 (June 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts